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AIM 
 
To evaluate the role of lactate as a neuroprotective agent in a rat model of 
focal cerebral infarction. 
 
 
OBJECTIVES 
 
1. To develop a rat model of focal cerebral infarction by temporary 
middle cerebral artery occlusion (MCAO). 
2. To assess the efficacy of lactate in reduction of infarct volume.  
 
 
 
 
INTRODUCTION 
 
Cerebral ischemia is a major pathophysiological factor contributing to neural 
injury in numerous clinical conditions (Gladden 2004) such as traumatic 
brain injury, vasospasm following subarachnoid hemorrhage and stroke 
syndromes.  Lactate (La) has traditionally been thought of as a ‘dead end’ 
product of anaerobic metabolism, and glucose stands unchallenged as the 
principle metabolic substrate of the mature brain (Chih et al. 2001). 
However, the recently proposed astrocyte-neuron lactate shuttle hypothesis 
(ANLSH) assigns a major metabolic role to brain-derived lactate.   
According to the ANLSH lactate is produced in an activity dependent 
manner and is then utilized by the active neurons to produce ATP (Brooks 
1985, Pellerin & Magistretti, 1994, 2003, 2008; Magistretti & Pellerin, 
1999; Magistretti et al. 1999; Bouzier-Sore et al. 2002; Pellerin, 2003). The 
active brain may also use lactate when glucose is temporarily unavailable.  
An animal model of focal cerebral ischemia was developed with 
indigenously developed modifications of the previously described 
techniques and then a study was carried out on this model to assess the effect 
of lactate infusion on infarct volume. 
 
LITERATURE REVIEW 
 
In 1950, von Muralt distinguished four different eras in the understanding of 
muscle chemistry: pre-lactic acid, lactic acid, phosphorylation, and myosin. 
The pre-lactic acid era began in 1808 with Berzelius's discovery of an 
elevated concentration of lactate in ‘the muscles of hunted stags’ (Brooks & 
Gladden, 2003).  
Fletcher & Hopkins (1907) ushered in the lactic acid era during which A. V. 
Hill's studies suggested that the lactic acid (La) was the immediate energy 
donor for muscle contractions.  
In 1920, Meyerhof demonstrated that glycogen was the precursor of La, and 
the 1930s marked the beginning of the phosphorylation period of muscle 
chemistry.  
In 1939, the myosin period began with the finding that the enzyme 
responsible for ATP hydrolysis was associated with the muscle protein, 
myosin (von Muralt, 1950) 
By the early 1940s, the full Embden-Meyerhof (glycolytic) pathway had also 
been elaborated. If we restrict our considerations to La and its metabolism, 
we might term the period from the 1930s to approximately the early 1970s 
the dead-end waste product era, when La was largely considered to be a 
dead-end metabolite of glycolysis resulting from muscle hypoxia 
(Wasserman, 1984). 
Lactic acid was also believed to be the primary cause of the slow component 
of the O2 debt (Margaria et al. 1933) and a major cause of muscle fatigue 
(Hermansen, 1981).  
Since the early 1970s, a ‘lactate revolution’ has occurred, and we are in the 
midst of the lactate shuttle era that began with the introduction of the lactate 
shuttle hypothesis by George Brooks (1985).  The evidence seems to suggest 
that lactate is an important intermediary in numerous metabolic processes, a 
particularly mobile fuel for aerobic metabolism, and perhaps a mediator of 
redox state among various compartments both within and between cells. 
 
Brain energy pathway - Conventional View 
Any increase in nervous system activity increases the energy requirements 
of the neurons, which is conventionally thought to be provided by glucose 
oxidation (Chih et al. 2001, Figure 1).  
 
 Figure 1:  Conventional scheme of neuronal metabolism.  
(O.P. - Oxidative Phosphorylation; Glc – Glucose;  Pyr – Pyruvate;  Lac – 
Lactate;  MCT – Monocarboxylate Transporters) 
 
Glucose use increases in both neurons and astrocytes during activity. 
Heightened sodium-potassium ATPase activity in both cell types during 
neural activity increases ATP consumption and stimulates glucose use by 
activating glycolytic enzymes. Glucose is transported into neurons and 
astrocytes via the glucose transporters GLUT-3 and GLUT-1 respectively.  
Glucose is metabolized to pyruvate (hereafter designated as glycolysis) to 
produce two ATPs in either cell type. Pyruvate is either converted to lactate 
(anaerobic glycolysis by LDH) or taken up by the mitochondria where it 
enters the TCA cycle and is metabolized via oxidative metabolism. Lactate 
produced by both neurons and astrocytes is transported to the extracellular 
space via MCT.  The increased energy demands resulting from neural 
activity are met by ATP generated from both glycolysis and oxidative 
metabolism in this model. The conventional hypothesis does not ascribe any 
particular fraction of glucose metabolism to either the aerobic or anaerobic 
pathways.  
 
Astrocyte Lactate Shuttle Hypothesis 
Pellerin & Magistretti (1994) challenged this conventional scheme of 
nervous system energetics with their introduction of the astrocyte–neuron 
lactate shuttle hypothesis (ANLSH, figure 2). In this model (Pellerin & 
Magistretti, 1994, 2003; Magistretti & Pellerin, 1999; Magistretti et al. 1999; 
Bouzier-Sore et al. 2002; Pellerin, 2003), glutamate that is released as a 
neurotransmitter from the neurons is primarily taken up into astrocytes via a 
transporter that carries one glutamate, three Na+, and one H+ inward while 
one K+ is moved out of the cell (Attwell, 2000). 
   
 
Figure 2:  Putative astrocyte neuron lactate shuttle hypothesis   
(Gluc - glucose; Gly - glycogen; Pyr - pyruvate; La - lactate;  Glu - 
glutamate; Gln - glutamine; GS - glutamine synthetase; LDH1 and LDH5 - 
specific forms of lactate dehydrogenase in neurons (LDH1) and astrocytes 
(LDH5); ECF - extracellular fluid; GLT-1 and GLAST -  glutamate 
transporters;  2: glia-specific Na+–K+ ATPase subunit)  
 
This astrocytic transport activity then leads to Na+–K+-ATPase activation 
(perhaps via an increase in [Na+] to restore ionic balance, and to glutamine 
synthesis from the glutamate that has been taken up. The energy costs of the 
ATPase pump and glutamine synthesis result in [ATP], [ADP], [Pi], and 
[AMP], which largely stimulate glycolysis in the astrocytes with resultant La 
production. Here, glycolytic enzymes may be compartmentalized with the 
ATPase pump and glutamine synthesis pathway, allowing preferential 
activation of the glycolytic energy system. La moves into the extracellular 
compartment along its concentration gradient via MCT1 transporters in the 
astrocyte plasma membrane. Next, extracellular space La rises, driving La 
into the neighbouring neurons via MCT2 transporters in the neuronal plasma 
membrane. Inside the neurons La, along with glucose, serves as an oxidative 
fuel for elevated neuronal energy metabolism that has been triggered by an 
activated Na+–K+-ATPase to restore ionic balance and resynthesis of 
glutamate from glutamine, largely derived from astrocytes. While glucose 
can be taken up by neurons via their GLUT3 transporters, larger amounts of 
glucose may be used by astrocytes, and taken up into astrocytes via their 
GLUT1 transporters. In fact, Loaiza et al. (2003) have reported that 
glutamate stimulates glucose transport into cultured hippocampal astrocytes 
more rapidly than any stimulation of mammalian glucose transport yet 
known. In short, in the ANLSH, much of the fuel for increased energy 
demands of neurons is supplied by La from surrounding astrocytes. As a 
result, metabolism of the astrocytes is largely glycolytic while that of the 
neurons is largely oxidative. The ANLSH has also been proposed for other 
support cell–neuron/receptor energetic interactions such as those between 
Schwann cells and peripheral neurons (Véga et al. 1998), and between 
Müller glial cells and photoreceptors (Poitry-Yamate et al. 1999). 
The implications of the ANLSH are extremely far-reaching. For example, 
apart from its inferences concerning basic mechanisms of nervous system 
metabolism, the ANLSH offers intriguing explanations for functional brain 
imaging (Magistretti &  Pellerin, 1999; Magistretti et al. 1999). Local brain 
activity is monitored by visualization of changes in blood flow, glucose 
usage, and oxygen consumption via positron emission tomography (PET), 
changes in blood oxygenation via functional magnetic resonance imaging 
(fMRI), and spatio-temporal patterns of metabolic intermediates such as 
glucose and La via magnetic resonance spectroscopy (MRS). Magistretti & 
Pellerin (1999) argue that the ANLSH ‘provides a cellular and molecular 
basis for functional brain imaging techniques’. It is possible that current 
functional neuroimaging is more a reflection of astrocyte function rather 
than neuronal function (Meeks & Mennerick, 2003). 
Overall, the model suggests that glial cells account for about 6.5% (two ATP 
from substrate phosphorylation in the glycolytic conversion of one glucose 
to two La) of nervous system activity while neuronal energy expenditure 
accounts for the other 93.5% (29 ATP from oxidation of two La) (Salway, 
1999).  For the glial cells, it has been proposed that one glycolytic ATP is 
used to extrude three Na+ ions via the Na+–K+-ATPase pump while the 
second ATP is spent to convert glutamate to glutamine (Magistretti & 
Pellerin, 1999).  However, it seems unlikely that metabolism is so tightly 
coupled and compartmentalized as to allow such strict stoichiometry. A 
more probable scenario may be a mixture of the ANLSH with the 
conventional view. In this scheme, astrocytes would utilize at least some of 
their own glycolytic products in oxidative metabolism and neurons would 
utilize some La from astrocytes in addition to endogenous, neuronal 
glycolytic products (Mangia et al. 2003b). 
 
Key points of evidence in support of the ANLSH 
1. Nuclear magnetic resonance spectroscopy has provided evidence of 
La utilization as an energy substrate in brain tissue, specifically as a 
neuronal fuel (Hassel & Brathe, 2000; Qu et al. 2000) 
2. There is a cell-specific expression of monocarboxylate transporters 
(MCTs) in the central nervous system. In cultured mouse cortex 
preparations, MCT1 and MCT1 RNA are found almost exclusively in 
astrocytes while MCT2 and its RNA are exclusive to neurons. (Bröer 
et al. 1997; Debernardi et al. 2003). Adult rat brain cells show a 
similar pattern.  As explained earlier MCT1 transports lactate out of a 
cell and MCT2 into the cell, making it likely that this differential 
expression of the two phenotypes of the transporter functions to move 
La from within the astrocytes into the neurons.  MCT1 is also present 
in endothelial cells of the blood–brain barrier (Mac & Nalecz, 2003). 
3. Specialized astrocytic processes are wrapped around synaptic contacts 
(Rohlmann & Wolff, 1996), and in most brain regions, the astrocytes : 
neuron ratio is 10: 1 (Bignami, 1991).  It is possible that they play 
more that a mechanical role in neuronal support. 
 
The most salient criticisms of ANLSH  
1. There is no solid explanation as to why neural activity either in situ or 
in vivo should activate glial glycolysis but not neuronal glycolysis 
(Chih et al. 2001). 
2. Neuronal activity has been reported to increase cytoplasmic pyruvate 
and NADH levels, making it unclear that increases in La are sufficient 
to drive the LDH reaction towards pyruvate and NAD+ formation (see 
Chih et al. 2001). 
3. Direct measurements of extracellular lactate and glucose in severe 
head injury in humans by microdialysis show increased lactate – 
glucose ratios result in worse outcome (Goodman JC et al, 1999). 
4. Whereas the astrocyte–neuron lactate shuttle predicts an initial La 
overproduction, recent experiments using time-resolved proton 
magnetic resonance spectroscopy found a significant decrease in La 5 
seconds after visual stimulation in humans (Mangia et al. 2003). 
 
Lactate in Animal Behaviour and Clinical studies  
Rice et al (2004) examined the usefulness of lactate administration in the 
attenuation of behavioral deficits following a moderate head injury in rats. A 
fluid percussion of 2.17atm was administered through the craniotomy onto 
the intact dura. In the experimental group (n=8), lactate infusion (100 
mM@0.65ml/hour))was started 30 minutes after lateral fluid percussion 
injury and continued for three hours. Control group consisted of eight rats in 
whom 0.9% saline was infused at the same rate that of the experimental 
group. They chose 30 minutes as this is the time frame when a moderately 
brain injured individual may arrive in an emergency room and treatment 
could be initiated. The cognitive deficits were measured by Water Maze 
Test, and neurons in CA1 and CA3 region of the hippocampus were 
counted.  The lactate infused animals demonstrated significantly less deficits 
than saline infused injured animals. Neuronal loss was not seen in either the 
CA1 or CA3 areas. They concluded that the lactate therapy amplifies a 
naturally occurring mechanism in the acutely injured brain. 
In another study (Glenn, 2003), a cohort of 49 brain-injured patients were 
subjected to 179 determinations of lactate metabolism by magnetic 
resonance spectroscopy over the first five days.  It was shown that cerebral 
uptake occurred in 76% of them, and that patients with a favorable outcome 
showed a greater brain lactate uptake when compared with those who had an 
unfavorable outcome.  
Our hypothesis is that the initial response of the brain to any injury is to have 
the astrocytes take up glucose and produce lactate for the neurons to use as 
an energy source. Exogenous supplements of lactate may enhance this 
response and minimize neuronal damage and synaptic disruption.  This study 
assessed the effect of lactate infusion on the infarct volume following 
temporary intraluminal occlusion of MCA in adult male Wistar rats. 
 
Laboratory model of focal cerebral infarction 
Desirable animal models are those that replicate features of human 
cerebrovascular syndromes. Rat models of focal cerebral ischemia have 
gained increasing acceptance in recent years owing to their relevance to the 
human clinical setting. MCAo (Middle cerebral artery occlusion) in the rat 
has been in use since 1975. 
One widely used technique of MCAo involves cauterization of the MCA via 
a craniotomy (Backhauss 1992); this technique is invasive and does not 
permit reperfusion. In human ischemic stroke, however, recirculation occurs 
frequently after focal ischemia, particularly in the case of cerebral embolism.  
In the rat, mechanical clipping of the MCA (Yanamoto 1998) and  
photothrombotic occlusion (Markgraf 2003) of the vessel  are in common 
use, but these techniques also involve a craniotomy.  
In 1986, Koizumi et al reported a novel, relatively noninvasive method of 
achieving reversible MCAo by the use of an intraluminal suture.  
Subsequently, Zea Longa et al (1988) reported a variation of this method and 
stated that their technique reliably produced regional infarcts.  Since then 
this method and its further modifications have been used extensively in 
stroke trials (Shimamura 2006, Zao 2008). This study has been conducted on 
a focal infarct model developed with modification of above mentioned 
technique. 
MATERIAL AND METHODS 
 
A total of 32 male adult Albino Wister rats weighing 250 – 350 grams were 
acquired from the animal facility house of the institute. 16 rats were 
allocated for standardization of the procedure another 16 rats were allocated 
for the main experiment. Financial assistance was obtained from FLUID 
grants committee and the necessary ethical clearance was obtained from the 
animal ethics committee, Christian Medical College, Vellore. All rats were 
fasted overnight and day night cycle was maintained.  
 
Over view of the procedure  
Anesthesia was induced with chloroform and maintained with an intra-
peritoneal injection of ketamine sulphate in doses of 40 – 80 mg/kg.   All 
rats underwent prophylactic tracheostomy. The femoral vein and the tail 
artery were cannulated with 24 G intravenous catheter to facilitate and blood 
sampling for sodium, glucose, lactate and arterial blood gases. Complete loss 
of righting reflex and loss of corneal reflex was taken as beginning of deep 
anaesthesia. At this moment, the tail artery was canulated with a heparin 
flushed PE 50 catheter for blood sampling. A rectal thermometer was used to 
monitor the temperature. 
The color of the eyes, pinna, respiratory rate, temperature were the clinical 
variables noted for each rat at the end of procedure. Blood was also analyzed 
at the end of procedure for pH, pO2, Sodium, Lactate and Glucose levels. 
The duration of the entire procedure and approximate blood loss were also 
recorded. Once the procedure was standardized, 8 rats were to be assigned to 
the drug arm (lactate solution) and another eight to be given normal saline as 
control. The surgeon was blinded to the study groups. Lactate was used as 
2ml solution of 60 mM sodium lactate where as 2 ml of 0.9% sodium 
chloride was used as control. Both these solutions were administered 
intraperitoneally over one and half hours at the rate of 20 units (0.5 ml) 
every 30 minutes from the time of induction of anesthesia. 
All rats included in the experiment underwent a standard surgical procedure 
which involved occlusion of right MCA with insertion of 4-0 nylon suture 
through the right ECA (modified, Zea Longa 1990).  This technique has 
been described in details below. Two hours following the procedure the rats 
were observed for neurological deficits and were graded by system proposed 
by Bederson et al. Rats were allowed to come out of anesthesia after 
completion of the surgery and food and water were given at libitum.  As a 
means of assessing adequacy of occlusion a neurological score was assigned 
to each animal 5 minutes before removing the occlusion and at the end of the 
24 hours following the occlusion. 
 
 
 
Figure 3: Operated rat with a left hind limb weakness. This severity of the 
neurological deficit was scored as 1.    
Neurological scoring (Bederson et al) 
0 - No deficit 
1 – One Limb weakness  
2 - Circling to affected side  
3 - Partial paralysis on affected side  
4 - No spontaneous motor activity 
Rats with Score 1 – 3 were included in the subsequent part of the 
experiment.  
The duration of occlusion was 120 minutes. Rats that did not demonstrate 
extremity weakness at least five minutes prior to reperfusion were excluded 
from the study. Reperfusion was performed under mild sedation. The suture 
was pulled back until a resistance was felt indicating that the tip had cleared 
the ACA-ICA lumen and then it was trimmed at the skin. Animals were 
allowed to survive for twenty four hours. 
Twenty four hours following the reversible occlusion of right MCA these 
animals were euthanized with deep chloroform anesthesia. Heads were 
quickly decapitated and then processed for making brain slices and 
subsequent image analysis in a standardized way as described below.  
A successful model was defined as rat showing 24 hours post surgical 
neurological deficit (Neurological grade 1-3) and a simultaneous 
documentation of infarct on TTC staining.  
 
 
 
 Preparation of suture material 
1. 5.0 cm long segments of 4-0 ethilon were prepared.  
2. To make the tip of the suture segment blunt; it was heated near a 
flame. (See figure 4) 
3. 20 mm distal part of the suture material was coated with Dr. Mac’s 
solution (commercially available preparation used for insulation of 
copper wires, contains epoxy resin 20% in ethyl alcohol) and dried in 
oven at 60 degree for one hour. 
4. Visual inspection of the tip to make sure that the blunting was 
complete.  Any sharp segment was discarded. 
5. At a distance of 17 mm from the rounded tip a permanent mark was 
made with print eraser so as to limit excessive insertion of the 
occluder.  
                   
 
 
Figure 4:  Bits of 4-0 ethilon used for MCAO viewed under microscope 
Surgical procedure 
 
Figure 5:  Representative diagram showing rat cerebrovascular anatomy.  
Rats were placed on a wooden slab measuring 12 x 7 cm. and covered with 
warm towel sheets to maintain the body temperature (See Figure 6).  All 
four limbs were extended and secured to the slab with an adhesive. A thread 
looping around the upper incisors was fixed to the slab to maintain the 
extension of neck. 
 
 
 
Figure 6:  Anaesthetized rat placed on a wooden block and limbs secured. 
Note that the linen covering the rat maintains the temperature. 
 
The operating microscope was now brought in and a midline vertical skin 
incision was made starting from the hyoid up to the manubrium sterni. 
(Figure 7) 
 
 
 
Figure 7:  Cervical region after retracting the skin flaps with stay sutures. 
 
The trachea was exposed in the midline and a square window made in two 
tracheal cartilages. The patency of the tracheostomy was checked with a 
wisp of cotton. The air eggressing from the trachea would cause movement 
of the cotton bristle, which confirmed the tracheostomy to be adequate.  The 
secretions could also be cleared with the help of cotton. With a combination 
of blunt and sharp dissection, the right common carotid artery (CCA) was 
exposed through the same incision. The CCA was identified in the carotid 
sheath lateral to the strap muscles near the tracheo esophageal groove.  The 
trachea and the strap muscles served as initial landmarks for the 
identification of CCA. It is important to note that CCA becomes superficial 
as it emerges into the neck and it is at this point where it can get damaged 
during dissection. Self-retaining retractors were applied with the lateral arm 
on the sternocleidomastoid and the medial arm on the strap muscles. The 
carotid sheath was held up with the help of micro forceps proximally and a 
small temporary occluder is placed on CCA. This temporary occluder served 
as a micro vascular clip that would prevent excessive ooze from the CCA if 
it was damaged distally. 
 
 
 
 
 
 
 
 Figure 8 (low magnification):  Right common carotid artery clamped with a 
temporary occluder (fine arrows). CCA is identified between the strap 
muscles (bold arrows) in the vicinity of the tracheo esophageal groove 
medially and the sternocleidomastoid laterally (broken arrows) 
  
The occluder was a small bit of PE- 50 catheter that was placed parallel to 
the CCA and in close proximity to it.  A loop of 4-0 silk was tied around the 
CCA and PE-50 to occlude the artery. This set-up was used to facilitate 
removal of the occlusion by cutting the 4-0 silk with a knife directly onto the 
PE-50 without damaging the artery.  Once the occluder was placed on the 
CCA, the carotid sheath was further dissected distally to expose the 
bifurcation and the external carotid artery. The various branches of the 
external carotid artery (ECA) were then finely dissected, exposed, ligated 
with 6 - 0 prolene and then cut. The prominent branches requiring ligation 
were superior thyroid artery, maxillary artery and the occipital artery. The 
latter branch arises proximally near the bifurcation and extreme care has to 
be taken while dissecting it off the internal carotid artery (ICA). A lymph 
node partially covering the carotid bifurcation needed to be carefully 
separated from the CCA and the ICA, a point in the dissection where these 
vessels were prone for damage. Once the lymph node was cleared out, the 
ECA was cut between the ligatures and then transposed inferiorly until it 
was parallel with the CCA. 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 9:  Isolated and transposed right ECA. Note that the common carotid 
artery is still clamped. 
 
Now the proximal part of the internal carotid artery (ICA) was isolated and 
the pterygopalytine artery (PPA) which is lateral to ICA was ligated with 6-0 
prolene. This bifurcation was quite deep and required good visualization.  
The ligature over the PPA should not be too far proximal as this would 
narrow the ostium of the ICA, and it should not be too distal as in that case 
the tip of the inserted occluder would lodge in PPA.  This could happen as 
the origin of the PPA is straighter. At this point ICA was the only remaining 
extra cranial branch of the CCA.  Next, a 4-0 silk suture was tied loosely 
around the mobilized ECA stump, and a temporary micro vascular clip was 
placed across ICA adjacent to PPA origin. 
 
 
Figure 10:  After dissecting the internal carotid artery and its branches, a 
temporary occluder has been placed to prevent the retrograde blood flow 
while doing arteriotomy.  
 
 A 5 cm length of 4-0 monofilament nylon sutures, its tip rounded by heating 
near the flame, was introduced into the ECA lumen through a puncture or 
through one of its terminal branches. The silk suture around the ECA stump 
was tightened around the intraluminal nylon to prevent bleeding, and the 
micro vascular clip removed. The nylon suture was advanced from the ECA 
to ICA until a resistance was felt to a maximum of 17 mm indicating that the 
blunted tip of the suture has passed the origin of MCA and reached the 
proximal segment of the anterior cerebral artery ACA 
 
 
Figure 11:  4-0 Ethilon has been passed into the transposed ECA stump and 
introduced further into the ICA to block the origin of MCA. 
  
Now, the intra luminal suture has blocked the origin of MCA, occluding all 
sources of   retrograde blood flow from ICA, ACA, and posterior cerebral 
artery. The incision was closed leaving behind 1 cm of nylon suture 
protruding beyond the skin so that it could be withdrawn later to allow 
reperfusion. The wound was closed keeping the tracheostomy site open.   
 
Preparation of Slices  
TTC as a staining agent: 
Different methods have been used to detect the morphological features of 
cerebral tissue after ischemic injury. The oxidation-reduction indicator 2,3,5-
triphenyltetrazolium chloride (TTC) has been used successfully for early 
histochemical diagnosis of myocardial infarction. The staining action of 
tetrazolium salts is based on the presence of a dehydrogenase. In normal 
tissue, dehydrogenase reduces TTC to formazan, which stains red. In 
ischemic or infarcted tissue dehydrogenase activity is reduced or eliminated 
and those areas remain unstained. 
Procedure:  
Rats were euthanised with deep chloroform. Decapitation was carried out 
with sharp scissors at the level of craniovertebral junction. The brain was 
carefully dissected en bloc within ten minutes. (figure 12) 
 
Figure 12:  Rat brain being isolated from the skull. 
 
The brain was then quickly transferred and cooled on a bed of ice for about a 
minute. It was then placed on the brain matrix (Plastics One TM, USA, see 
figure 13) and sliced coronally at 2 mm intervals starting from the frontal 
tip. Four slices were made out of one brain.  
 
 
 
 Figure 13:  Brain matrix that was used to make 2 mm slices of rat brain.  
 
These slices were freed from the dura and the vascular tissue. Then these 
were soaked for 10 minutes in a solution of 0.1% TTC in 0.1mol/Litre PBS 
(pH 7.4), warmed to 37 degrees in a water bath. Excess TTC was drained 
and slices refrigerated at 4 degrees in 10 % formalin. 
 
 
 
 
 Figure 14:  A typical stained rat brain slice. Red areas are the viable area 
and the yellow area is the infarcted area.   
 
Imaging of Slices 
The stained slices were photographed using a 2.0 mega pixel digital camera 
attached to the operating microscope. The resulting image was then 
transferred and then saved as an uncompressed tagged image file format file 
on a personal computer. Imaging software was acquired from NIH (National 
Institute of Health, USA) as free trial software. The software was also 
loaded in the same computer.  An independent assessor blinded to the study, 
manually delineated the infarct and total areas with a computer mouse. Two 
readings were averaged for each section. If the difference of more than 10% 
was noted between these two readings, then the third reading was taken and 
the value that was closer was finalised.  The infarcted volume was calculated 
by multiplying this by the slice thickness.   
 
Statistical Methodology 
All values, except for neurological score, are presented as mean +/- SD. 
Infarct size, body weight, and physiological variables were analyzed with 
the unpaired t test. Neurological scores are reported as the median (quartile 
deviation). A value of p < 0.05 was considered significant. 
 
 
 
 
 
 
 
RESULTS 
 
Out of 32 rats allotted, the initial plan was to use 16 rats to establish the 
model and the other 16 for the actual experiment.  However 24 rats were 
needed to develop and standardize the surgical technique as a satisfactory 
infarct with clinical deficit was not obtained in the first 19 rats.  The 20th to 
24th rats (n=5) showed consistent neurological deficits correlating with the 
focal cerebral infarct as documented by TTC staining. Table 1 shows the 
probable causes of failure in the first 19 rats.  
 
Table 1: Reasons for failure while developing and standardizing the model 
Rat number Reason for failure 
1 Death due to anesthetic complications 
2 Death due to anesthetic complications 
3 Death due to anesthetic complications 
4 Death due to anesthetic complications 
5 Death - intra op hemorrhage (pre cannulation) 
6 Death - intra op hemorrhage (pre cannulation)  
7 Death - subarachnoid hemorrhage due to perforation at 
ICA bifurcation 
8 Death - subarachnoid hemorrhage due to perforation at 
ICA bifurcation 
9 Same as above 
10 Death due to airway compromise  
11 Death due to airway compromise 
12 Death due to airway compromise 
13 Death - intra op hemorrhage (during cannulation)  
14 Death - intra op hemorrhage (during cannulation) 
15 No deficit – failure of occlusion by 4-0 ethilon coated 
with poly L Lysine 
16 No deficit – failure of occlusion by 3-0 ethilon coated 
with super glue 
17 No deficit – failure of occlusion by 5-0 ethilon coated 
with super glue 
18 No deficit – 5-0 ethilon coated with Mac’s solution, no 
occlusion 
19 No deficit – 4-0 ethilon coated with Mac’s solution did 
not reach origin of MCA 
 
 As a result only eight rats were available for the final experiment, and were 
allocated equally into the lactate and control groups (lactate group = 4, 
control group = 4). 
 
Table 2:  Intraoperative parameters monitored 
Variable Lactate Control p value 
Body weight (gms) 313.75 ± 22.87  310±18.26 Not significant
Temperature (degrees C) 37.1±0.35 37.4±0.8 Not significant
Sodium (meq/L) 140.0±5.94 140.75±4.57 Not significant
Glucose (meq/L) 175.25±8.18 177.51±4.18 Not significant
Serum lactate(meq/L) 2.92±0.22 1.05±0.26 <0.0001 
pH 7.30±0.03 7.45±0.05 Not significant
Surgery duration (min) 41.25±2.50 51.25±10.31 Not significant
Anaesthesia duration (min) 81.25±4.79 76.25±4.75 Not significant
Blood loss (no. of pledgets) 2.0 2.5 Not significant
pO2(mm Hg) 104.25±4.57 102.75±6.08 Not significant
 
Neurological Score  
The median neurological score prior to sacrifice was 1.0 in the lactate group 
(range 1- 2) while it was 2.0 in the control group (range 1-2). (p=0.6) (see 
table 3) 
Table 3: Comparison of neurological scores in the study groups 
 
 
 
 
 
 
 
Infarct volume   
The mean infarct volume was 119 ± 34.6 mm3 in the lactate group while it 
was 180.61 ± 37.26 mm3 in the saline group. (p = 0.05).  The detailed values 
of infarct volume in all rats are entered in Table 4. 
 
Rat number Lactate group Control group  
1 2 2 
2 1 2 
3 1 2 
4 1 1 
Table 4(a):  Infarcted area and total area per brain slice (in pixels) in the 
lactate group as seen in figure 14. Each rat brain was sectioned into four 
slices rostrocaudally (a-d).   
 
 
Rat 
(Lactate) 
Infarct area 
in pixels 
Total area in 
pixels 
Ratio 
1a 224 4854 0.05 
1b 1556.5 5203 0.30 
1c 1496 5649 0.26 
1d 1060.5 5569 0.19 
2a 277.5 5029 0.06 
2b 958 5464 0.18 
2c 1436.5 5541 0.26 
2d 1335.5 5741 0.23 
3a 277.5 5537 0.05 
3b 877 5691 0.15 
3c 1030.5 5945 0.17 
3d 545.5 5765 0.09 
4a 269.5 5015 0.05 
4b 1287.5 5662 0.23 
4c 387.5 5987 0.06 
4d 401.5 5839 0.07 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14:  TTC stained axial sections of the rat brain that were  
 
infused with sodium lactate (experimental group). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4(b):  Infarcted area and total area per brain slice (in pixels) in the 
control group as seen in figure 15. 
 
Rat 
(Control) 
Infarct area in 
pixels 
Total  area in 
pixels 
Ratio 
1a 1036.5 5003 0.21
1b 1869.5 5334 0.35
1c 1770.5 5665 0.31
1d 1434 5608 0.26
2a 890 5382 0.17
2b 1381 5666 0.24
2c 986.5 5883 0.17
2d 1306 5721 0.23
3a 1127 5084 0.22
3b 1709 5214 0.33
3c 1479.5 5558 0.27
3d 1394.5 5721 0.24
4a 344.5 5035 0.07
4b 962 5503 0.17
4c 1434.5 5805 0.25
4d 1102.5 5687 0.19
 
 
 
 
 
 
 
 Figure 15:  TTC stained axial sections of the rat brain that were infused with 
normal saline (control group).
DISCUSSION 
 
Development of the model  
Rat models of focal cerebral ischemia have gained increasing acceptance in 
recent years owing to their similarity to human clinical syndromes and the 
difficulty of experimenting with primate models.  Various techniques to 
produce a reliable infarct models such as cauterization of the MCA via a 
craniotomy (Backhauss 1992), mechanical clipping of the MCA 
(Yanamoto1998) and photothrombotic occlusion (Markgraf 1994) have been 
described.  Koizumi et al (1986) and Zea Longa et al (1988) reported a 
novel, relatively noninvasive  method of  achieving reversible MCAo by the 
use of an intraluminal suture which has come to be a widely used stroke 
model.  However reproduction of their technique requires specialized 
equipment such as ventilators, microclips, microelectrocoagulation and 
sophisticated imaging techniques.  This study, despite many initial setbacks, 
demonstrates that the model can be reproduced with easily available 
equipment and techniques.  The major problems encountered and the way 
they were solved will be discussed. 
Rat Handling 
The investigator had no previous experience in handling rats.  The tasks of 
picking up the animal from the cage, identification and marking, recognition 
of behavioural traits, examination of physical signs like colour of the eyes, 
pinna and the respiratory rate were all learnt during the development of the 
model.  It is essential to get accustomed to animal characteristics and 
behaviour for conducting a successful experiment.  
Rat anaesthesia 
Drugs and Dosages 
An ideal rat anaesthetic agent is the one that has good sedative and 
anaesthetic properties that last for a prolonged period without compromising 
breathing and airway. Chloroform was used initially, but proved to have an 
ill-sustained effect (only 1 minute), and on increasing the dose it caused 
severe respiratory depression resulting in death of the rats. However, 0.5ml 
of 2% chloroform soaked in cotton was found to be an ideal inducing agent. 
The rats were placed in the ether glass jar with the cotton impregnated with 
chloroform. By careful and repeated observation, it was noticed that the drop 
in the respiratory rate to 50 per minute, loss of postural reflex and fading of 
the red colour of the eye marked the onset of anaesthesia.  This effect lasted 
only for a minute, providing a window period for administering the long 
duration intraperitoneal anaesthetic.  
Intraperitoneal ketamine (60-80 mg/kg) and injection atropine (0.1 mg/kg) 
were administered intraperitoneally with an insulin syringe. It is important to 
pinch and lift up the skin over the abdomen to avoid injection into the 
subcutaneous space or into the bowel. The dose has to be fractionated into 
three parts; one third is administered after induction, one third prior to skin 
incision and the rest mid-way during the surgical procedure. A single bolus 
administration resulted in severe haemodynamic compromise and death. 
This protocol of fractionation developed by trial and error provided a smooth 
and sustained anaesthesia for approximately two and a half hours.  
Airway and ventilation  
Administration of ketamine caused excessive parasympathetic activity 
resulting in salivation and tachycardia. Anaesthesia for prolonged duration 
required protection of airway as intraoperative deaths due to asphyxia were 
noted in the first few rats.  Since no animal ventilator, endotracheal 
intubation equipment or monitoring devices were available, several different 
methods to secure the airway were tried.  Initial attempts to cannulate the 
trachea with the help of an intravenous 16 gauge plastic cannula were 
unsuccessful.  However an elective tracheostomy was found to be extremely 
effective in safeguarding the airway. A small window was created in the 
midline of the trachea by cutting the cartilage with microscissors. This not 
only facilitated the patency of the airway but also provided access for 
periodic aspiration of the mucoid secretions that accumulated in the trachea. 
The skin edges were sutured to the cartilaginous edge with the help of 5-O 
Prolene (Polypropylene).  Development of tracheostomy was an important 
landmark in preventing rat deaths due to asphyxia.  Following regular use of 
tracheostomy, none of the rats died primarily due to airway compromise.  
Blood sampling 
The tail artery was cannulated with a PE 50 catheter for sampling. The blood 
samples were analysed with the help of automated Blood Gas analyzer that 
provided information regarding pH, PaO2, PaCO2, lactate, glucose, sodium 
and potassium.  Due to financial constraints, these investigations were done 
during only after the model was successfully developed, and at the end of 
the surgical procedure.  
 
Equipment  
The investigator required help initially with the handling of 
microinstruments and the microscope, as well as in the initial surgical 
approach and identification of various anatomical structures.  The first few 
surgeries were performed with a senior guide (AGC). Various other tools 
such as microvascular clips, self-retaining retractors were indigenously 
designed and put into the use gradually.  With increasing experience the 
surgical and anaesthesia time decreased significantly.  
 
Appropriate suture material  
Despite gaining expertise in the anaesthesia, microsurgical skills, and 
keeping the rat alive till the recovery phase, no neurological deficits or 
infarct formation were obtained. Four factors, all related to the suture 
material which was used to occlude the origin of MCA, were found to affect 
the results. The first thing the thickness of the suture material - out of 3-O, 4-
O and 5-O Ethilon, 4-O Ethilon was found to be the best.  The second 
requirement was that the tip had to be blunted with heat.  Non-blunting of 
the tip resulted in perforation of the internal carotid bifurcation causing fatal 
subarachnoid haemorrhage.   
Dr. Mac’s solution 
The third important factor was material used to coat the suture material.   
Initially, poly L-lysine was used as described in literature but proved 
unsuitable.  After experimentation the solution used to insulate copper wire 
in electrical equipment was found to be effective.   
Marking on the suture 
Many authors have suggested that the firm resistance felt after inserting a 
certain length of the suture marks the placement of the tip into the ACA 
thereby blocking all blood flow into the MCA. However in this experiment it 
was found that this was causing perforation of the blood vessel before the 
pressure could be appreciated.  If the suture material was placed short of the 
occlusion only subcortical infarcts with no demonstrable neurological 
deficits were obtained, as seen in figure 16. 
 
 Figure 16:  Left sided subcortical infarct (yellow unstained section) 
 
From the cadaveric measurements done on the rats a length of 17-18 mm of 
the suture was found to almost always result in proper placement with 
occlusion of the origin of MCA.  Hence the strategy was changed and the 
sutures were marked at a distance of 17 mm from the tip and inserted up to 
this point. This marking prevented excessive insertion of the suture and still 
provided effective blockade of the MCA.  Marking a thin suture also proved 
difficult, and finally regular alcohol based white print eraser was used to 
mark the distance. This was the fourth important factor in preparing the 
suture material, and was finally achieved with the twentieth rat. 
 
Slice making - Brain matrix 
The brain matrix is a device to make evenly spaced slices out of the brain. 
This was not available in India and was essential to perform the infarct 
analysis. Hence a plastic version was imported from USA and used for the 
experiment. 
  
Cost effective way of staining slices 
Staining technique described in Western literature used a 2% solution of 
TTC.  Based on a paper published by Murthy et al  (2004) from CDRI 
Lucknow a 0.5% solution was used and found to be effective. This reduced 
the cost of the staining technique by half. 
 
Imaging of slices  
The operating microscope in the animal house did not have an attached 
digital camera port.  Images taken directly with a digital camera through the 
eyepiece were not of good resolution, but images were taken with a 2.0 
mega pixel cell phone CCD camera were found to be of good quality, 
probably because of the smaller lens.  
 
Imaging software 
Image analysis software was required for an accurate assessment of the 
infarct size. A demo version of Image J was acquired from NIH (National 
Institute of Health, Bethesda, USA) and then was used to delineate and 
quantify the infarct and the area of the brain section. 
 
Limitations of the model 
In this experiment a recognised technique of producing infarctions in rats 
has been considerably modified for it to be performed with minimal 
equipment and locally available materials, which are important factors in a 
resource constrained environment. 
The rats in this study were not ventilated and did not have continuous 
invasive blood pressure monitoring or saturation monitors. Surrogate clinical 
markers like respiratory rate, color of the pinna, color of the eyes, posturing 
reflex were used as a guide to assess various physiological parameters. Even 
blood gas analysis was performed only once at the end of each surgery.  
Though there was no difference between the two groups it is entirely 
possible that there was some variation in physiological parameters during 
the procedure, which in turn could affect infarct size independent of 
experimental solutions.  
All vessels that were sacrificed in this study were individually isolated and 
divided between two ligatures. This was time consuming and difficult, 
especially for deeper structures like pterygopalatine artery.  A bipolar 
coagulator should be used in future experiments. 
A number of similar experiments performed used various imaging 
modalities to assess ischemia and infarction including MRA, doppler and 
perfusion studies.  Only clinical evaluation for deficits was used in this 
study, and no imaging was performed. 
Even minimal subarachnoid hemorrhage can be a confounding factor in this 
experiment, and previous reports indicated that laser Doppler-guided 
placement of the suture might reduce the incidence of SAH.  We could not 
do this, but in our final series of eight rats none had any evidence of SAH.   
Lactate as an alternative fuel 
For much of the 20th century, lactate was largely considered a dead-end 
waste product of glycolysis due to hypoxia, the primary cause of the O2 debt 
following exercise, a major cause of muscle fatigue, and a key factor in 
acidosis-induced tissue damage. Since the 1970s, a ‘lactate revolution’ has 
occurred.  There is now significant experimental support for a cell-to-cell 
lactate shuttle, along with mounting evidence for astrocyte–neuron, lactate–
alanine, peroxisomal and spermatogenic lactate shuttles.  
In our study we tried to assess the role of lactate in limiting infarct size. To 
our knowledge this is the first time lactate has been assessed in a ischemic 
stroke like clinical paradigm.  The lactate levels were found to be 
significantly higher in the experimental group than the control group. 
Though the infarct was smaller in the group infused with lactate (119 mm3 
with lactate, 181 mm3 in controls), the difference was barely statistically 
significant.  The sample size was smaller than initially planned, due to the 
fact that standardizing the model proved to be much more difficult than 
anticipated.  However lactate does seem to decrease infarct size, possibly via 
the ANLSH.  A larger trial is needed to further elucidate the role of La in 
preventing secondary brain injury. 
 
 
CONCLUSIONS 
The experiment describes a simple technique to make a reliable animal 
model of focal cerebral infarct that can be performed with minimal 
equipment and materials.  Lactate appears to decrease infarct size, 
supporting the astrocyte neuron lactate shuttle hypothesis.   
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